Albany College of Pharmacy and Health Sciences vs Albizu University-Miami
Side-by-side college ROI comparison from College Scorecard data
Verdict
Albany College of Pharmacy and Health Sciences has a 100.0% graduation rate compared to Albizu University-Miami at 100.0%. Average median debt: Albany College of Pharmacy and Health Sciences at $44,584 vs Albizu University-Miami at $38,228. Average first-year post-graduation earnings: $59,200 vs $47,667.
| Metric | Albany College of Pharmacy and Health Sciences | Albizu University-Miami |
|---|---|---|
| Graduation Rate | 100.0% | 100.0% |
| School Type | Private | Private |
| State | Ny | Fl |
| Avg Median Debt Average median debt across all tracked majors | $44,584 | $38,228* |
| Avg 1yr Earnings Average first-year earnings across all tracked majors | $59,200* | $47,667 |
| Majors Tracked | 5 | 3 |
| Best ROI Major | Pharmacy, Pharmaceutical Sciences, and Administration (72/100)* | Psychology (60/100) |
| Best Major Debt | $46,266 | $38,228* |
| Best Major 1yr Earnings | $62,000* | $48,000 |
Albany College of Pharmacy and Health Sciences has a 100.0% graduation rate compared to Albizu University-Miami at 100.0%. Average median debt: Albany College of Pharmacy and Health Sciences at $44,584 vs Albizu University-Miami at $38,228. Average first-year post-graduation earnings: $59,200 vs $47,667.
Explore More
Comparing entity A and entity B on U.S. college cost, debt, and post-graduation earnings requires lining up the underlying the U.S. Department of Education College Scorecard data side by side. The table above runs the comparison on the canonical fields; the narrative below identifies the factor or factors that drive the most meaningful difference between the two.
Practical use of the comparison: read the data above, then drill into the individual entity A and entity B detail pages for the underlying breakdown. A pairwise comparison answers the relative question; the per-entity pages answer the absolute question.
Source: U.S. Department of Education College Scorecard, 2026.